A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration
Clinical trial NCT04684394 · TERMINATED
Trial details
- NCT number
- NCT04684394
- Sponsor
- Gemini Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-29
- Primary completion
- 2022-01-10
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.